Innovative anti-Xa assay sets new standard in anticoagulant diagnostics
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban
Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban